News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
News
FDA
Nature Reviews Drug Discovery Release: 2003 Approvals: A Year Of Innovation And Upward Trends
October 19, 2005
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Although the number of new molecular entities approved in 2003 was only marginally higher than in 2002, approvals for innovative drugs were encouraging.
Twitter
LinkedIn
Facebook
Email
Print
FDA
Approvals
MORE ON THIS TOPIC
Podcast
Sarepta Gets Reprieve, RFK Jr.’s New Changes, Roche’s Alzheimer’s Comeback and Q2 Earnings
July 30, 2025
·
2 min read
·
Heather McKenzie
FDA
Prasad Out at CBER Following Sarepta Rollercoaster and Conservative Criticism
July 29, 2025
·
1 min read
·
Heather McKenzie
Gene therapy
FDA Does 180 on Sarepta, Freeing DMD Gene Therapy for Ambulatory Patients
July 28, 2025
·
2 min read
·
Annalee Armstrong
Duchenne muscular dystrophy
Sarepta Denies Latest Patient Death is Elevidys-Linked as FDA Launches Probe
July 28, 2025
·
2 min read
·
Tristan Manalac